Fundraising Fox
🦊/Companies
Sign in

Pinnacle Medicines

Doylestown, US · Founded 2024 · 22 employees on LinkedIn · 7 known investors

Find your way into Pinnacle Medicines

286 people in our graph share verified history with the Pinnacle Medicines team — schools, employers, funds. One of them is your warm intro.

Brian Bustamante-Nicholsonunlockedknows Chengzao Sun · together at Brown University (overlapped)
×4knows the team · via Nanjing University
×2knows the team · via The Scripps Research Institute
×4knows the team · via Brown University
knows the team · via Indian Institute of Technology, Guwahati

Pinnacle Medicines develops oral peptide-based therapies designed to deliver antibody-like efficacy in pill form for patients with chronic diseases. The company focuses on oral drug formulation in the biotech and pharmaceutical space.

BiotechDigital Health

Founders & leadership

Pinnacle Medicines was founded in 2024 by Chengzao Sun and Sandeep Somani.

CSChengzao Sun
Chengzao SuninCo-Founder, CSOChengzao Sun brings over two decades of peptide drug discovery and development experience from roles at Amylin, BMS, Merck, and Janssen, with expertise spanning oral and injectable peptide formulations from discovery through Phase 3 clinical trials.
SS
Sandeep SomaniinCo-Founder, CTOComputational chemist with expertise in protein structure, biomolecular modeling, and drug formulation engineering. Somani has over a decade of experience in computational chemistry applied to both biologics—including antibody engineering and vaccine design—and small-molecule drug discovery.

Investors · 7

Foresite CapitalWest Hollywood
Quan CapitalShanghai
RA CapitalBoston
LAVreported · 2 sourcesHong Kong · $5M – $15M
OrbiMedreported · 2 sourcesNew York · $1M – $75M

Also in the syndicate · 2

Hankang CapitalLogos Capital

Funding

SEC filings, press & company announcements

$89M disclosed across 1 of 2 rounds · 2026

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Two Life Sciences Companies with Doylestown Connections Raise $119Mbucksco.today · Apr 2026The next oral peptide bet: Pinnacle Medicines gets $89M from US and China investorsendpoints.news · Mar 2026Pinnacle Medicines raises $89M for oral peptide developmentaxios.com · Mar 2026OrbiMed-backed Pinnacle adds $89M series B to power oral peptide pipelinefiercebiotech.com · Mar 2026Pinnacle Medicines, a Pioneer of Oral Peptide Therapeutics, Announces Oversubscribed $89 Million Series B Financing to Advance Pipeline into Clinical Trialsprnewswire.com · Mar 2026Pinnacle Medicines Raises $89M in Series B Fundingfinsmes.com · Mar 2026

Frequently asked questions

What does Pinnacle Medicines do?
Pinnacle Medicines develops oral peptide-based therapies designed to deliver antibody-like efficacy in pill form for patients with chronic diseases. The company focuses on oral drug formulation in the biotech and pharmaceutical space.
Who founded Pinnacle Medicines?
Pinnacle Medicines was founded by Chengzao Sun, Sandeep Somani in 2024.
Who are Pinnacle Medicines's investors?
Pinnacle Medicines's investors include Foresite Capital, Quan Capital, RA Capital, LAV, OrbiMed.
How much funding has Pinnacle Medicines raised?
Pinnacle Medicines has disclosed $89M raised across 1 of its 2 known rounds.
Where is Pinnacle Medicines headquartered?
Pinnacle Medicines is headquartered in Doylestown, US.